LON:MRM

16421 (MRM.L) Share Forecast, Price & News

Add

Compare

Today's Range N/A

50-Day Range N/A

52-Week Range N/A

VolumeN/A

Average VolumeN/A

Market CapitalizationN/A

P/E RatioN/A

Dividend YieldN/A

BetaN/A

Receive MRM News and Ratings via Email

Sign-up to receive the latest news and ratings for 16421 (MRM.L) and its competitors with MarketBeat's FREE daily newsletter.

About 16421 (MRM.L)

Metrodome Group plc is engaged in the licensing, marketing and distribution of feature films, television and video programming primarily through Cinemas, Digital Versatile Disc (DVD) and Video on Demand (VOD) channels. The Company owns, manages and distributes film, Television and digital content. The Company operates in two segments: The first operating segment is based on its original business activity of United Kingdom film distribution. The second segment, Hollywood Classics, an international sales agency, reflects Hollywood Classics Limited, a 100% owned subsidiary. It works with some of the business, including Charlize Theron (Monster), Jake Gyllenhaal (Donnie Darko), Colin Firth (Genov'), Maggie Gyllenhaal (Sherrybaby), Michael Caine & Demi Moore (Flawless),Jet Li (The Warlords), Kristin Scott-Thomas (Leaving) and Tilda Swinton (I Am Love). The Company's subsidiaries include Metrodome Distribution Ltd, Cinedome Ltd, Hollywood Classics Ltd and Devil Lies Beneath Ltd.

Headlines

No headlines for this company have been tracked by MarketBeat.com

Industry, Sector and Symbol

Stock Exchange: LON
Industry: Offices of Lawyers
Sub-Industry: N/A
Sector: Professional, Scientific, and Technical Services
Current Symbol: LON:MRM
Previous Symbol
CUSIP: N/A
CIK: N/A
Web: www.distribution.metrodomegroup.com
Phone: +44-20-75177550
Employees: N/A
Year Founded: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Net Income: N/A
Net Margins: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Price-To-Earnings

Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A

Miscellaneous

Outstanding Shares: N/A
Market Cap: N/A
Next Earnings Date: N/A
Optionable: Not Optionable

MarketRank^™

Overall MarketRank^™

0.93 out of 5 stars

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for 16421 (MRM.L).

4.7 Community Rank

Outperform Votes
16421 (MRM.L) has received 46 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
16421 (MRM.L) has received 19 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
16421 (MRM.L) has received 70.77% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about 16421 (MRM.L) and other stocks. Vote “Outperform” if you believe MRM will outperform the S&P 500 over the long term. Vote “Underperform” if you believe MRM will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
16421 (MRM.L) does not currently pay a dividend.
Dividend Growth
16421 (MRM.L) does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, 16421 (MRM.L) insiders have not sold or bought any company stock.

0.0 Earnings and Valuation

See Top Rated MarketRank™ Stocks Here

16421 (MRM.L) (LON:MRM) Frequently Asked Questions

What stocks does MarketBeat like better than 16421 (MRM.L)?: Wall Street analysts have given 16421 (MRM.L) a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but 16421 (MRM.L) wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.
Who are some of 16421 (MRM.L)'s key competitors?: Some companies that are related to 16421 (MRM.L) include 435793 (ACM.L) (ACM), Asian Citrus (ACHL), CompuGroup Medical SE & Co. KGaA (CMPUY), CUE Energy Resources (CUE), Graphene NanoChem (GRPH), Inova Resources Limited, (IVA), Jacobs Engineering Group (J), Magellan High Conviction Trust (MHH), Mawson Infrastructure Group (MIGID), Sunrise Energy Metals (SRL) and Value Exchange International (VEII).
View all of MRM's competitors.
What is 16421 (MRM.L)'s stock symbol?: 16421 (MRM.L) trades on the London Stock Exchange (LON) under the ticker symbol "MRM."
How do I buy shares of 16421 (MRM.L)?: Shares of MRM and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.
How many employees does 16421 (MRM.L) have?: 16421 (MRM.L) employs 2,020 workers across the globe.
What is 16421 (MRM.L)'s official website?: The official website for 16421 (MRM.L) is www.distribution.metrodomegroup.com.
Where are 16421 (MRM.L)'s headquarters?: 16421 (MRM.L) is headquartered at Beaufort Court, Suite 31, Admirals Way, LONDON, E14 9XL, United Kingdom.
How can I contact 16421 (MRM.L)?: 16421 (MRM.L)'s mailing address is Beaufort Court, Suite 31, Admirals Way, LONDON, E14 9XL, United Kingdom. The company can be reached via phone at +44-20-75177550.

This page was last updated on 10/16/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms

Your Ultimate Investing Toolkit

Just $1.00 for your first month.